Trial intelligence / Profile preview

Shenguo Elderly Cold Granules in Middle-aged and Elderly Patients with Deficiency-type Common Cold

CTR20140146Phase 2Completed

Sponsor
Shaanxi Tianfang Technology
Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of shenguo laonian ganmao granules in upper respiratory infection (URI), nasopharyngitis, sponsored by Shaanxi Tianfang Technology. Started Apr 2014; status: completed.

02

Drugs

shenguo laonian ganmao granules
03

Conditions

upper respiratory infection (URI)nasopharyngitis

Beyond the preview

Go deeper on CTR20140146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call